Beyond enhanced activation of CD8+NKG2D+ cells by MV-Edm-infected HCC cells both in vitro and in vivo, we found that intratumoural administration of MV-Edm also increased infiltration of intravenously transferred CD8+NKG2D+ cells. This evidence concerns the gene CD8A and hepatocellular carcinoma.